| Literature DB >> 35953801 |
Zhu-Yun Liu1, Lin Wei2, Ri-Chun Ye1, Jiao Chen1, Dan Nie1, Ge Zhang3, Xiao-Pei Zhang4.
Abstract
BACKGROUND: Pulmonary infection is a frequent complication among stroke patients and adversely affects clinical outcomes, increases the length of hospitalization stay and costs, and aggravates the financial burden of the national medical health system. Early identification and management of high-risk patients are necessary and imperative to reduce the incidence of stroke-associated pneumonia (SAP). AIM: The evidence-based practice project evaluated the effectiveness of a standard care bundle intervention in preventing the occurrence of SAP.Entities:
Keywords: Evidence-based practice; Patient safety; Pneumonia; Prevention; Quality improvement; Stroke
Mesh:
Year: 2022 PMID: 35953801 PMCID: PMC9367053 DOI: 10.1186/s12883-022-02826-8
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.903
Fig. 2The workflow of SAP prevention of patients with stroke
Fig. 1The flowchart of the study. A2DS2: Age, Atrial fibrillation, Dysphagia, Sex, Stroke Severity
Baseline characteristics of the study population (n = 86)
| Variables | Preimplementation group | Postimplementation group | ||
|---|---|---|---|---|
| Age, years old | 69 (64, 76) | 68 (63, 74) | 846.0 | 0.497 |
| Sex, males | 24 (55.8) | 23 (53.5) | 0.047 | 0.829 |
| Employment | 2.708 | 0.305a | ||
| Employed | 1 (2.4) | 5 (11.6) | ||
| Retired | 35 (85.4) | 32 (74.4) | ||
| Unemployed | 5 (12.2) | 6 (14.0) | ||
| Risk factors | ||||
| Hypertension | 33 (76.7) | 31 (72.1) | 0.244 | 0.805 |
| Diabetes | 13 (30.2) | 15 (34.9) | 0.212 | 0.818 |
| Dyslipidemia | 10 (23.3) | 12 (27.9) | 0.244 | 0.805 |
| Atrial fibrillation | 14 (32.6) | 7 (16.3) | 3.087 | 0.131 |
| Smoking | 11 (25.6) | 14 (32.6) | 0.508 | 0.635 |
| Alcohol consumption | 4 (9.3) | 8 (18.6) | 1.550 | 0.351 |
| Stroke etiology | 2.437 | 0.543a | ||
| Cardioembolism | 12.3) | 0 (0.0) | ||
| Large-vessel disease | 24 (55.8) | 30 (69.8) | ||
| Small-vessel disease | 15 (34.9) | 11 (25.6) | ||
| Other causes | 3 (7.0) | 2 (4.7) | ||
| OCSP classification | 0.497 | 0.946 | ||
| Total anterior circulation infract | 7 (16.3) | 7 (16.3) | ||
| Partial anterior circulation infract | 24 (55.8) | 25 (58.1) | ||
| Posterior circulation | 6 (14.0) | 7 (16.3) | ||
| Lacunar infarct | 6 (14.0) | 4 (9.3) | ||
| Treatment protocols | 0.483a | |||
| Drugs | 37 (86.0) | 40 (93.0) | ||
| Non-drugs | 6 (14.0) | 3 (7.0) | ||
| Admission NIHSS score | 6 (3, 13) | 6 (4, 10) | 879.0 | 0.693 |
| Admission BP, mmHg | ||||
| Systolic BP | 160 (140, 175) | 153 (136, 175) | 842.0 | 0.476 |
| Diastolic BP | 87 (76, 95) | 91 (81, 96) | 788.5 | 0.240 |
| A2DS2 score | 6 (5, 6) | 6 (5, 7) | 802.5 | 0.262 |
| Oral hygiene score | 23 (17, 26) | 22 (18, 26) | 903.5 | 0.856 |
| NRS-2002 | 0.05 | 1.000 | ||
| ≥ 3 | 27 (62.8) | 28 (65.1) | ||
| < 3 | 16 (37.2) | 15 (34.9) | ||
| 30 ml water swallowing test | 2.828 | 0.243 | ||
| III | 22 (51.2) | 23 (53.5) | ||
| IV | 13 (30.2) | 17 (39.5) | ||
| V | 8 (18.6) | 3 (7.0) | ||
| The degree of dysphagia | 2.729 | 0.395a | ||
| 3 | 1 (2.3) | 0 (0.0) | ||
| 4 | 28 (65.1) | 23 (53.5) | ||
| 5 | 12 (27.9) | 18 (41.9) | ||
| 6 | 2 (4.7) | 2 (4.7) | ||
*The difference was statistically significant
aFisher’s exact test
Results are presented as n (%), mean ± standard deviation or median (interquartile range)
OCSP Oxfordshire Community Stroke Project; NIHSS National Institutes of Health Stroke Scale; BP blood pressure; ADS Age, Atrial fibrillation, Dysphagia, Sex, Stroke Severity; NRS nutrition risk screening
Outcome indicators of the study population on the day of admission (n = 86)
| Variables | Preimplementation group | Postimplementation group | ||
|---|---|---|---|---|
| Aspiration | 0 (0.0) | 0 (0.0) | / | |
| White blood cells (109/L) | 7.43 (5.89, 8.93) | 7.30 (5.60, 8.30) | 784.5 | 0.226 |
| Procalcitonin (ng/ml) | 0.045 (0.033, 0.056) | 0.048 (0.036, 0.072) | 737.5 | 0.106 |
| Hypersensitive C-reactive protein (mg/L) | 5.20 (4.02, 6.92) | 5.10 (3.24, 6.81) | 819.0 | 0.362 |
| Hemoglobin (g/L) | 116 (108, 136) | 120 (109, 133) | 865.0 | 0.607 |
| Serum albumin (g/L) | 36.93 ± 3.29 | 38.24 ± 3.31 | −1.838 | 0.070 |
aFisher’s exact test
Results are presented as n (%), mean ± standard deviation or median (interquartile range)
All indicators of the study population (n = 86)
| Variables | Preimplementation group | Postimplementation group | ||
|---|---|---|---|---|
| SAP | 16 (37.2) | 6 (14.0) | 6.108 | 0.025* |
| Indicators of infection | ||||
| White blood cells (109/L) | 7.49 (5.51, 9.30) | 7.20 (5.51, 8.40) | 863.5 | 0.598 |
| Procalcitonin (ng/ml) | 0.083 (0.054, 0.095) | 0.054 (0.044, 0.076) | 610.5 | 0.007* |
| Hypersensitive C-reactive protein (mg/L) | 8.74 (4.56, 13.60) | 5.20 (3.40, 6.70) | 636.5 | 0.013* |
| Length of stay, days | 13 (9, 18) | 11 (8, 14) | 687.0 | 0.040* |
| Total cost, USD | 20,351.62 (12,794.51, 32,790.98) | 18,139.21 (12,658.4, 32,666.31) | 843.0 | 0.481 |
| NIHSS score | 4 (2, 13) | 6 (2, 9) | 923.0 | 0.990 |
| Aspiration | 16 (37.2) | 4 (9.3) | 9.382 | 0.004* |
| NRS-2002 | 2.549 | 0.171 | ||
| ≥ 3 | 32 (74.4) | 25 (58.1) | ||
| < 3 | 11 (25.6) | 18 (41.9) | ||
| Serum albumin (g/L) | 33.92 ± 2.90 | 35.83 ± 4.20 | −2.459 | 0.016* |
| Oral hygiene score | 19 (15, 21) | 15 (13, 18) | 530.5 | 0.001* |
| 30 ml water swallowing test | 6.766 | 0.149 | ||
| I | 2 (4.7) | 10 (23.3) | ||
| II | 15 (34.9) | 12 (27.9) | ||
| III | 16 (37.2) | 15 (34.9) | ||
| IV | 6 (14.0) | 4 (9.3) | ||
| V | 4 (9.3) | 2 (4.7) | ||
| The degree of dysphagia | 7.097 | 0.131 | ||
| 0 | 2 (4.7) | 10 (23.3) | ||
| 2 | 15 (34.9) | 12 (27.9) | ||
| 4 | 17 (39.5) | 16 (37.2) | ||
| 5 | 6 (14.0) | 4 (9.3) | ||
| 6 | 3 (7.0) | 1 (2.3) | ||
*The difference was statistically significant
Results are presented as n (%), mean ± standard deviation or median (interquartile range)
SAP stroke-associated pneumonia; NIHSS National Institutes of Health Stroke Scale; NRS nutrition risk screening